scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1026731729 |
P356 | DOI | 10.1038/SJ.LEU.2404694 |
P698 | PubMed publication ID | 17443226 |
P50 | author | Henrik Hasle | Q40506155 |
Jan-Henning Klusmann | Q42231158 | ||
P2093 | author name string | Creutzig U | |
Kaspers GJ | |||
Zwaan CM | |||
Reinhardt D | |||
van den Heuvel-Eibrink MM | |||
Hahlen K | |||
P2860 | cites work | Pattern of malignant disorders in individuals with Down's syndrome. | Q34571958 |
JAK2T875N is a novel activating mutation that results in myeloproliferative disease with features of megakaryoblastic leukemia in a murine bone marrow transplantation model | Q35849213 | ||
Activating alleles of JAK3 in acute megakaryoblastic leukemia | Q40255542 | ||
Mutations in KIT and RAS are frequent events in pediatric core-binding factor acute myeloid leukemia | Q40405651 | ||
AML patients with Down syndrome have a high cure rate with AML-BFM therapy with reduced dose intensity | Q46513852 | ||
An inherited mutation leading to production of only the short isoform of GATA-1 is associated with impaired erythropoiesis | Q55670499 | ||
JAK3 mutations occur in acute megakaryoblastic leukemia both in Down syndrome children and non-Down syndrome adults | Q79657116 | ||
Developmental stage-selective effect of somatically mutated leukemogenic transcription factor GATA1 | Q81749163 | ||
P433 | issue | 7 | |
P921 | main subject | acute megakaryoblastic leukemia | Q4677933 |
P304 | page(s) | 1584-1587 | |
P577 | publication date | 2007-04-19 | |
P1433 | published in | Leukemia | Q6534498 |
P1476 | title | Janus kinase mutations in the development of acute megakaryoblastic leukemia in children with and without Down's syndrome | |
P478 | volume | 21 |